Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 21Unknown 13Recruiting 5Active not recruiting 5Withdrawn 2Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Leukemia 1

Interventions

Specimen Handling 8venetoclax 7Azacitidine 6Cyclophosphamide 5Biopsy 4fludarabine phosphate 3Tacrolimus 3Etoposide 3fludarabine 2Stem Cell Transplantation 2Mitoxantrone 2Melphalan 2Magnetic Resonance Spectroscopy 2Cytarabine 2vactosertib 1regorafenib 1prednylidene 1methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside Pt(II) 1iadademstat 1gilteritinib 1eltrombopag 1deltacortene 1decitabine and cedazuridine drug combination 1cyclo-tetrakis(bis(1-phenyl-3-methyl-4-benzoylpyrazolon-5-ato)mu-oxotitanium(IV)) 1brincidofovir 1beta-apocarotenoid-14',13'-dioxygenase 1azathiopurine 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1aldesleukin 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Prednisolone × Other hematologic neoplasm × Clear all
NCT00991744 2012-10-10

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

Nordic Society for Pediatric Hematology and Oncology

Phase 3 Suspended
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡